… the anti-hyperalgesic effects of the intrathecal Y1 agonist. We … induction of both neuropathic
and inflammatory allodynia (28)… reduced both neuropathic behavioral and spinal molecular …

… neuropeptide Y (NPY… intrathecal administration of Y1 agonists) to inhibit mechanical and
thermal hypersensitivity and spinal neuron activity in rodent models of neuropathic, inflammatory…

… genes implicated in neuropathic and inflammatory mechanical … intrathecal Y1 agonists act
at GRP-INs to inhibit neuropathic … and potently reduce the behavioral signs of neuropathic pain …

… Moreover, mTOR-mediated metabolic reprogramming was required for induction of inflammatory
… We found that Mtor deletion in microglia reduced microgliosis; however, it did not have …

… We hypothesized that Y2 function depends on inflammation or nerve … Results: We report that
intrathecal BIIE0246 increased … and molecular markers of inflammatory or neuropathic pain. …

… intrathecal injection could attenuate both mechanical and cold allodynia in chronic constructive
injury neuropathic … widely inhibition of neuropathic and inflammatory pain behavior. The …

… (ie, neuropeptide Y, galanin, and enkephalins) in response to injury and inflammation [10]. …
100 ng in 20 µL of saline, centrally by intrathecal (it) injection in the lumbar region (between …

… coexpress itch-associated markers such as natriuretic peptide … , intrathecal PYY 3–36 reduced
the scratch behavior induced by IL-31. Our findings imply that the NPY/Y 2 system reduces …

… of neuropathic pain, bone cancer pain, inflammatory pain and … Three groups of neuropathic
pain rats received intrathecal … Therefore, our results revealed that dexamethasone reduces …

… Intrathecal dynorphin administration, as well as stimulation of … Inflammation reduced
mechanical force necessary to induce … , chronic constriction injury, painful peripheral neuropathy, …